Allworth Financial’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-545
| Closed | -$2.46K | – | 5227 |
|
|
2025
Q4 | $2.46K | Buy |
545
+112
| +26% | +$574 | ﹤0.01% | 4042 |
|
|
2025
Q3 | $2.33K | Hold |
433
| – | – | ﹤0.01% | 3929 |
|
|
2025
Q2 | $2.35K | Buy |
+433
| New | +$1.72K | ﹤0.01% | 3634 |
|
|
2025
Q1 | – | Sell |
-83
| Closed | -$329 | – | 4086 |
|
|
2024
Q4 | $329 | Sell |
83
-629
| -88% | -$1.81K | ﹤0.01% | 3696 |
|
|
2024
Q3 | $2.09K | Buy |
712
+585
| +461% | +$1.93K | ﹤0.01% | 2951 |
|
|
2024
Q2 | $467 | Buy |
+127
| New | +$415 | ﹤0.01% | 3387 |
|
|
2023
Q4 | – | Sell |
-37
| Closed | -$253 | – | 3495 |
|
|
2023
Q3 | $253 | Hold |
37
| – | – | ﹤0.01% | 3200 |
|
|
2023
Q2 | $386 | Buy |
+37
| New | +$331 | ﹤0.01% | 2946 |
|
|
2023
Q1 | – | Sell |
-262
| Closed | -$1.58K | – | 3215 |
|
|
2022
Q4 | $1.58K | Buy |
+262
| New | +$1.94K | ﹤0.01% | 2320 |
|
Allworth Financial's CVAC Position: Q1 2026 in Review
Allworth Financial sold out of CureVac (CVAC) in Q1 2026, closing a stake of 545 shares — an estimated $2.46K sold.
Allworth Financial first reported a position in CVAC in Q4 2022 and held it in 9 quarters. The position peaked at $2.46K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Allworth Financial reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Allworth Financial sold 545 CureVac shares in Q1 2026, an estimated $2.46K.
- Allworth Financial first reported a position in CureVac in Q4 2022 and held it in 9 quarters.
- Allworth Financial's CureVac position peaked at $2.46K in Q4 2025.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.